GI-NEU
IMPACT OF COLOSTRUM-BASED NEUTRACEUTICALS ON FUNCTIONAL GASTROINTESTINAL DISORDERS
| Coordinatore | ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS
Organization address
address: CHARILAOU THERMI ROAD 6 KM contact info |
| Nazionalità Coordinatore | Greece [EL] |
| Totale costo | 646˙672 € |
| EC contributo | 646˙672 € |
| Programma | FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013) |
| Code Call | FP7-PEOPLE-2012-IAPP |
| Funding Scheme | MC-IAPP |
| Anno di inizio | 2013 |
| Periodo (anno-mese-giorno) | 2013-10-01 - 2017-09-30 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS
Organization address
address: CHARILAOU THERMI ROAD 6 KM contact info |
EL (THERMI THESSALONIKI) | coordinator | 214˙344.02 |
| 2 |
IMEDICA SA
Organization address
address: STRADA SOS BUCURESTI PLOIESTI 141D contact info |
RO (BUCARESTI) | participant | 164˙083.44 |
| 3 |
KALITE SISTEM LABORATUVARLARI AS
Organization address
address: Degirmen sok Ar Plaza B Blok 16 contact info |
TR (Istanbul) | participant | 140˙143.56 |
| 4 |
UNIVERSITA DEGLI STUDI DELLA TUSCIA
Organization address
address: VIA S MARIA IN GRADI 4 contact info |
IT (VITERBO) | participant | 128˙101.36 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'The aim of this proposal is to create a multiannual joint programme of collaboration between research-intensive non-commercial (academic) and commercial (industry) organisations to increase knowledge on the effects of colostrum-based neutraceuticals on functional gastrointestinal disorders (FGID). Functional gastrointestinal disorders such as irritable bowel syndrome represent well-known issues, yet the vast majority of attempts to address them to date have been led by either the public or the private sector alone. The current proposal is designed to exploit the complimentary expertise of non-commercial and commercial organisations through knowledge sharing and transfer between sectors. This will be achieved by establishing a Network of Excellence (NoE) that will incorporate staff secondments and the recruitment of researchers from outside the partnership for the purpose of networking, training activities, workshops, and joint research. Thus, this proposal will foster mutual understanding of the different cultural settings and skill requirements of the non-commercial and commercial sectors, encouraging entrepreneurship and long-term intersectoral collaboration regarding the effects of colostrum-based neutraceuticals on functional gastrointestinal disorders. Eventually, this partnership may help translate creative ideas into innovative products and processes that can efficiently address existing challenges on gastrointestinal issues.'